NOBIVAC DHP

Country: New Zealand

Language: English

Source: Ministry for Primary Industries

Active ingredient:

canine distemper virus (attenuated); canine parvovirus (attenuated); canine adenovirus type 2 (attenuated)

Available from:

Schering-Plough Animal Health Limited

INN (International Name):

canine distemper virus (attenuated), canine adenovirus type 2 (attenuated), canine parvovirus (attenuated)

Composition:

canine distemper virus (attenuated) 0 vaccine; canine parvovirus (attenuated) 0 vaccine; canine adenovirus type 2 (attenuated) 0 vaccine

Therapeutic area:

Vaccine

Authorization status:

ACVM Registered

Authorization date:

1987-05-06

Summary of Product characteristics

NOBIVAC DHP
25 doses – Insert Card and Label
A005526
Page 1 of 5
NOBIVAC DHP
23-Nov-22
Insert Card – Front panel
RESTRICTED VETERINARY MEDICINE
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
NOBIVAC
® DHP
25 vials of combined live attenuated freeze-dried canine distemper,
adenovirus type 2 and
parvovirus vaccine.
To be reconstituted with Nobivac Diluent or Nobivac Lepto I.
ACVM Registration No. A005526.
25 X 1 dose
MSD AH Logo
Insert Card – Inside panels
RESTRICTED VETERINARY MEDICINE
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
NOBIVAC
® DHP
DESCRIPTION
Nobivac DHP is a live attenuated freeze-dried vaccine offering
protection against canine
distemper, infectious hepatitis and parvovirus in dogs.
Each vial (1 dose when reconstituted) contains:
•
Canine distemper virus, strain Onderstepoort
≥10
4
TCID
50
•
Canine adenovirus type 2, strain Manhattan LPV3
≥10
4
TCID
50
•
Canine parvovirus, strain C154
≥10
7
TCID
50
The diluent (Nobivac Diluent) is phosphate buffered saline. Nobivac
Lepto I (A007832) may be
used as diluent.
INDICATION
Active immunisation of healthy dogs against canine distemper virus,
canine adenovirus type 1 and
type 2 and canine parvovirus.
The puppy programme can be completed from 10 weeks of age and
following completion, the
components of Nobivac DHP have been shown to protect against canine
distemper virus, canine
parvovirus and canine adenovirus for at least three years. The onset
of immunity is one week
following completion of primary vaccination. Nobivac DHP can be used
in pregnant bitches.
DOSAGE AND ADMINISTRATION
Reconstitute each single dose (vial) of the vaccine with one vial (1
mL) of Nobivac Diluent or
Nobivac Lepto I vaccine, and administer by subcutaneous injection.
When the vaccine is
NOBIVAC DHP
25 doses – Insert Card and Label
A005526
Page 2 of 5
NOBIVAC DHP
23-Nov-22
reconstituted with Nobivac Diluent the diluent volume can be reduced
to a minimum of 0.5 mLs if
desired to reduce the volume of the reconstituted vaccine; this
applies only t